Delivery Order SPE2DX15D3404-SPE2DX24F1DNB
Award Date
8/9/24
Potential Completion Date
8/12/24
Potential Value
$4.3K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,406.23 firm fixed-price contract is for the supply of 4,565,693,581 units of the pharmaceutical product dapagliflozin 10 mg tablets. The award has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $6,450.70 and issued by the Defense Logistics Agency (DLA). The contract is for the delivery of the pharmaceutical product Dapagliflozin 5 mg Tablet, a medication used to treat type 2 diabetes. The order has a firm fixed-price pricing type and an ultimate completion date of September 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is a Delivery Order valued at $8,372.91 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of 4566904877 - DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product used for diabetes management. The contract has an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,077,688 tablets of the medication dapagliflozin 10 mg. The $5,948.05 firm fixed-price contract has an ultimate completion date of April 30, 2025 and is not a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,941,013 units of Dapagliflozin 10 mg tablets, a prescription medication. The order has a ceiling value of $3,969.09 and a completion date of September 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB24D3013|SPE2DB25FFKXS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,443.60 firm-fixed-price delivery order is for the supply of 4,567,926,303 tablets of the diabetes medication Dapagliflozin 10 mg. The contract has an ultimate completion date of April 16, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a $9,081.39 firm fixed-price delivery order for 4568628324 - DAPAGLIFLOZIN 5 MG TABLET 30S, a diabetes medication. The contract has an ultimate completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $1,224.71 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,840 units of dapagliflozin 10 mg tablets. The contract has a period of performance through September 18, 2024 and was awarded on September 17, 2022. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,539.39, is a delivery order for the supply of 4567957850 DAPAGLIFLOZIN 10 MG TABLET 30S, a diabetes medication. The contract is not set aside and is a firm fixed-price agreement with an ultimate completion date of April 18, 2025. Additionally, AmerisourceBergen Drug Corp holds a significant...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $8,611.02 firm-fixed-price delivery order is for the supply of 4,565,766,279 units of the prescription drug dapagliflozin 10 mg tablets. The contract has an ultimate completion date of September 12, 2024 and does not utilize a set-aside. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA...